Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria.

MLA

Malkin, Elissa M., et al. “Phase 1 Clinical Trial of Apical Membrane Antigen 1: An Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria.” Infection and Immunity, vol. 73, no. 6, June 2005, pp. 3677–85. EBSCOhost, https://doi.org/10.1128/IAI.73.6.3677-3685.2005.

APA

Malkin, E. M., Diemert, D. J., McArthur, J. H., Perreault, J. R., Miles, A. P., Giersing, B. K., Mullen, G. E., Orcutt, A., Muratova, O., Awkal, M., Zhou, H., Wang, J., Stowers, A., Long, C. A., Mahanty, S., Miller, L. H., Saul, A., & Durbin, A. P. (2005). Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. Infection and Immunity, 73(6), 3677–3685. https://doi.org/10.1128/IAI.73.6.3677-3685.2005

Chicago

Malkin, Elissa M, David J Diemert, Julie H McArthur, John R Perreault, Aaron P Miles, Birgitte K Giersing, Gregory E Mullen, et al. 2005. “Phase 1 Clinical Trial of Apical Membrane Antigen 1: An Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria.” Infection and Immunity 73 (6): 3677–85. doi:10.1128/IAI.73.6.3677-3685.2005.